NAS10028,958S&P7,624−0.52%GOLD$4,023+0.37%BTC$79,848−1.17%VIX19.45+2.21%live tape · as of 04:14 UTC
The Screen · Basic Materials · Gold
KGCKinross Gold Corp
KGC · the NYSE · USD · Market cap $26.5B
Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.17, read 2026-10-25
Ethical passes the values gate
Price22.34 USD
Fair value27.81
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Distribution27.79-19.6% to today ✓Markup gives way to Distribution after a 16% rise in 9 weeks
2026-08-03Read Markup23.92-6.6% to today Distribution gives way to Markup after a 6% slide in 5 weeks
2026-07-02Read Distribution25.58-12.7% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Kinross Gold Corp holds its Distribution at $22.34. The statistical read favours the sellers, held for 56 days.
As held on the ledger · 2026-10-23
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 56 days
Price at the screen
$22.34
Valuation
8.49 trailing · 8.34 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.52
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
5.95%
Below 33%
Interest-bearing debt is just 5.9% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.80%
Below 33%
Cash held in interest-bearing accounts and securities is 0.8% of assets, under the one-third limit.
Pass
Receivables
14.72%
Below 49%
Money owed to the company is 14.7% of assets, under the 49% limit.
Pass
Revenue purity
1.04%
Below 5%
Only 1.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Kinross Gold clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 6%, inside the ~33% line, and interest is about 1% of its income, under the ~5% line, so it passes.
Read as at 2026-10-25. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KGC's ethical verdict changes
Today KGC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 24.5% margin of safety to the base estimate.
Third-party analyst targets: 10 covering, consensus Buy. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Gold miner looks cheap until the cycle turns
Picture a miner pulling gold from the ground while prices sit high. Kinross shows 61 percent revenue growth, 36 percent margins and a 35 percent return on equity, all at a forward multiple of 7.4 times. Those figures catch the eye, yet the business sits in a cyclical industry where peak earnings often arrive with the lowest multiples.
We pass because the narrow moat and gold price dependence make this a classic value trap rather than a bargain. The 35 percent margin of safety to our fair value looks attractive on paper, but earnings can collapse when metal prices normalise, wiping out the apparent discount.
Analysts see upside to 38 dollars and the ethical screen clears, yet history shows these setups rarely reward patient capital once the cycle rolls over. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
KGC trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-21Distribution$23.85+0.5%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
2026-10-14Distribution$23.74-14.6%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
2026-09-03Markup$30.26+26.5%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 26.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
2026-08-03Markup · changed$23.92-6.5%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
2026-07-18Distribution$25.58+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it D. Technically it is holding around 0% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 60%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (11 analysts) rates it buy, with a mean price target of $41.
2026-07-03Distribution$25.58+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Distribution$25.58Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.